Benitec Biopharma
BNTC
BNTC
37 hedge funds and large institutions have $290M invested in Benitec Biopharma in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
21% more capital invested
Capital invested by funds: $240M → $290M (+$50M)
4.07% more ownership
Funds ownership: 81.82% → 85.89% (+4.1%)
Holders
37
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$15.4M | |
| 2 | +$11.9M | |
| 3 | +$4.04M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.25M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.62M |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$452K | |
| 3 | -$204K | |
| 4 |
Citigroup
New York
|
-$82.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$24.6K |